Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
letter
. 1994 Feb;54(2):385–386.

mtDNA: Pathogenic or nonpathogenic sequence changes.

J Poulton, L A Bindoff
PMCID: PMC1918168  PMID: 8304353

Full text

PDF

Page 385

385

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Petty R. K., Harding A. E., Morgan-Hughes J. A. The clinical features of mitochondrial myopathy. Brain. 1986 Oct;109(Pt 5):915–938. doi: 10.1093/brain/109.5.915. [DOI] [PubMed] [Google Scholar]
  2. Poulton J., Turnbull D. M., Mehta A. B., Wilson J., Gardiner R. M. Restriction enzyme analysis of the mitochondrial genome in mitochondrial myopathy. J Med Genet. 1988 Sep;25(9):600–605. doi: 10.1136/jmg.25.9.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Tatuch Y., Christodoulou J., Feigenbaum A., Clarke J. T., Wherret J., Smith C., Rudd N., Petrova-Benedict R., Robinson B. H. Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet. 1992 Apr;50(4):852–858. [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES